Xylooligosaccharides (XOS)
A prebiotic that raises bifidobacteria at unusually low doses, around 1–3 g per day. The microbiome effect is repeatable in small trials, but clinical outcomes have barely been studied.
Evidence last reviewed: August 2026
What the science says
- Bifidogenic effect at low doses Moderate evidence
A double-blind, placebo-controlled crossover trial in healthy adults found that 1.4–2.8 g/day of XOS increased bifidobacteria and slightly modulated immune markers. An earlier controlled study reached the same conclusion: XOS raises bifidobacteria but not lactobacilli.
- Metabolic effects in prediabetes Limited evidence
A small pilot study in healthy and prediabetic adults found XOS altered gut bacteria, but it was underpowered for glucose or clinical endpoints and had no proper control arm for those outcomes.
- Digestive symptoms Limited evidence
No adequately sized randomized trial has tested XOS for constipation, IBS or bloating as a primary outcome.
Dosage & safety
Scientific references
- Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study
- Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota
- Xylooligosaccharide supplementation alters gut bacteria in both healthy and prediabetic adults: a pilot study
Where to buy
Referral link — this site may earn a commission on purchases.
Related in Gut health
- Probiotics Moderate evidence
- Psyllium Husk (fiber) Strong evidence
- L-Glutamine Limited evidence
- Oregano Oil Limited evidence
- Ginger Moderate evidence
- Inulin (Prebiotic Fiber) Moderate evidence